CRISPR-associated Single Guide RNA can often require long (100+ bases) synthetic nucleic acids as part of the therapeutic product. The accurate measurement and identification of the Full Length Product and its related impurities is required in order to satisfy regulatory guidelines. We will be presenting work describing the use of complementary techniques, such as LC-UV, ESI-MS and others, to accurately characterize the product profile.
